Cancer Research Coordinating Committee (CRCC) Funded Publications
Parent: University of California Research Initiatives
eScholarship stats: Breakdown by Item for June through September, 2026
| Item | Title | Total requests | Download | View-only | %Dnld |
|---|---|---|---|---|---|
| 17z5v0x6 | Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer | 213 | 102 | 111 | 47.9% |
| 65m374m7 | Oil-in-Water-in-Oil Multinanoemulsions for Templating Complex Nanoparticles | 176 | 110 | 66 | 62.5% |
| 0d34348t | Metabolite Responsive Nanoparticle-Protein Complex | 151 | 42 | 109 | 27.8% |
| 0ww2h0j5 | Erythrocyte-derived nano-probes functionalized with antibodies for targeted near infrared fluorescence imaging of cancer cells | 127 | 31 | 96 | 24.4% |
| 8ck6g0xp | A DNA aptamer for binding and inhibition of DNA methyltransferase 1. | 114 | 27 | 87 | 23.7% |
| 4wn320f9 | Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition. | 112 | 26 | 86 | 23.2% |
| 7f71c92q | Investigations into Wnt modulation of p27(KIP1) turnover and the E3 ligase substrate adaptor DDB1 and CUL4 Associated Factor 4 | 106 | 81 | 25 | 76.4% |
| 17k970vv | Syrbactin Structural Analog TIR-199 Blocks Proteasome Activity And Induces Tumor Cell Death. | 97 | 32 | 65 | 33.0% |
| 46n9603r | Scalable Total Synthesis, IP3R Inhibitory Activity ofDesmethylxestospongin B, and Effect on Mitochondrial Function andCancer Cell Survival | 75 | 27 | 48 | 36.0% |
| 3c03q2r2 | Rapid Enrichment and Detection of Extracellular Vesicles Enabled by CuS-Enclosed Microgels. | 72 | 29 | 43 | 40.3% |
| 6476b5js | Automatic Small RNA Extraction and Processing by a Multichannel/Multiwell Chip | 68 | 21 | 47 | 30.9% |
| 9qw9t9zc | Structure and function of G protein-coupled receptor oligomers: implications for drug discovery | 68 | 32 | 36 | 47.1% |
| 9wq0h1n3 | Adenosine A2a receptors form distinct oligomers in protein detergent complexes | 64 | 28 | 36 | 43.8% |
| 3012r2z7 | Copy number networks to guide combinatorial therapy of cancer and proliferative disorders | 56 | 22 | 34 | 39.3% |
| 6s658298 | Pre-clinical development of gene modification of hematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy | 31 | 0 | 31 | 0.0% |
Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.